You have access
Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration
FRANCESCO PASQUALETTI, ALESSANDRA GONNELLI, ALESSANDRO MOLINARI, MARTINA CANTARELLA, SABRINA MONTRONE, AGOSTINO CRISTAUDO, DAVIDE BALDACCINI, ROBERTO MATTIONI, DURIM DELISHAJ, VALENTINA MAZZOTTI, RICCARDO MORGANTI, PAOLA COCUZZA, MARIA GRAZIA FABRINI, GIUSEPPE LOMBARDI, ROBERTA RUDÀ, RICCARDO SOFFIETTI and FABIOLA PAIAR
Anticancer Research October 2018, 38 (10) 5877-5881; DOI: https://doi.org/10.21873/anticanres.12930
